These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10975684)

  • 1. Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management.
    Majorana A; Schubert MM; Porta F; Ugazio AG; Sapelli PL
    Support Care Cancer; 2000 Sep; 8(5):353-65. PubMed ID: 10975684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral health of adult patients undergoing hematopoietic cell transplantation. Pre-transplant assessment and care.
    Bogusławska-Kapała A; Hałaburda K; Rusyan E; Gołąbek H; Strużycka I
    Ann Hematol; 2017 Jul; 96(7):1135-1145. PubMed ID: 28194493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral graft-versus-host disease.
    Kuten-Shorrer M; Woo SB; Treister NS
    Dent Clin North Am; 2014 Apr; 58(2):351-68. PubMed ID: 24655527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation.
    da Fonseca MA; Hong C
    Pediatr Dent; 2008; 30(2):98-104. PubMed ID: 18481573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 180-day screening study for predicting the risk factors for developing acute oral Graft-versus-Host disease in paediatric patients subjected to allogenic haematopoietic stem cells transplantation.
    Defabianis P; Braida S; Guagnano R
    Eur J Paediatr Dent; 2010 Mar; 11(1):31-4. PubMed ID: 20359279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral graft-versus-host disease.
    Schubert MM; Correa ME
    Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
    Elad S; Levitt M; M Y S
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation.
    Brand HS; Bots CP; Raber-Durlacher JE
    Br Dent J; 2009 Nov; 207(9):E17; discussion 428-9. PubMed ID: 19893563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
    Kharfan-Dabaja M; Mhaskar R; Reljic T; Pidala J; Perkins JB; Djulbegovic B; Kumar A
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010280. PubMed ID: 25061777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral lesions in paediatric patients with graft-versus-host disease.
    Condò R; Maturo P; Perugia C; Docimo R
    Eur J Paediatr Dent; 2011 Mar; 12(1):50-4. PubMed ID: 21434736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management.
    Hull K; Kerridge I; Avery S; McCullough M; Ritchie D; Szer J
    Intern Med J; 2015 Jul; 45(7):702-10. PubMed ID: 26134695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral complications following allogeneic hematopoietic cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
    Souchet L; Ahmad I; Hamzy F; Ceballos P; Desbrosses Y; Ravinet A; Turlure P; Villate A; Vigarios E; Borel C; Yakoub-Agha I; Guillaume T
    Bull Cancer; 2020 Dec; 107(12S):S122-S129. PubMed ID: 32532421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral chronic graft-versus-host disease: What the general dental practitioner needs to know.
    Haverman TM; Raber-Durlacher JE; Raghoebar II; Rademacher WMH; Rozema FR; Hazenberg MD; Epstein JB; Treister NS
    J Am Dent Assoc; 2020 Nov; 151(11):846-856. PubMed ID: 33121606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis.
    Tollemar V; Tudzarovski N; Warfvinge G; Yarom N; Remberger M; Heymann R; Garming Legert K; Sugars RV
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1971-1979. PubMed ID: 32659433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Pyogenic Granuloma After Bone Marrow Transplant in the Pediatric/Adolescent Population: Report of 5 Cases.
    Cheney-Peters D; Lund TC
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):570-3. PubMed ID: 27271813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation.
    Anand A; Anandi P; Jain NA; Lu K; Dunavin N; Hourigan CS; Le RQ; Chokshi PD; Ito S; Stroncek DF; Sabatino M; Barrett AJ; Battiwalla M
    Support Care Cancer; 2016 Feb; 24(2):815-822. PubMed ID: 26190358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental caries as a risk factor for bacterial blood stream infection (BSI) in children undergoing hematopoietic cell transplantation (HCT).
    Abduweli Uyghurturk D; Lu Y; Urata J; C Dvorak C; Den Besten P
    PeerJ; 2022; 10():e14040. PubMed ID: 36172496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
    Robien K; Schubert MM; Bruemmer B; Lloid ME; Potter JD; Ulrich CM
    J Clin Oncol; 2004 Apr; 22(7):1268-75. PubMed ID: 15051775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral graft-versus-host-disease: implications for dental professionals].
    Raghoebar II; Raber-Durlacher JE; Laheij AMGA; Rozema FR
    Ned Tijdschr Tandheelkd; 2020 Feb; 127(1):89-95. PubMed ID: 32271325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.